Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Ironwood Pharma (IRWD) Reports Q2 Loss Per Share of 34c, Offers Guidance
August 5, 2015 4:23 PM EDTIronwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.34), may not compare to the analyst estimate of ($0.22). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $36.53 million.
2015 Financial Guidance.
Ironwood continues to expect its 2015 total operating expenses to... More
